US Broker Ratings

Bicycle Therapeutics plc (BCYC) Stock Analysis: High Potential Upside with Promising Pipeline

Bicycle Therapeutics plc (BCYC), a UK-based biotechnology innovator, is catching the attention of investors with its groundbreaking approach to developing novel therapies for underserved diseases. Despite the challenges inherent in..

Geron Corporation (GERN) Stock Analysis: Exploring a Potential 192% Upside for Healthcare Investors

Geron Corporation (NASDAQ: GERN), a notable player in the biopharmaceutical landscape, presents intriguing opportunities for investors looking to engage in the dynamic healthcare sector. With a market capitalization of $791.14..

MBX Biosciences, Inc. (MBX) Stock Analysis: Potential 170.77% Upside in Biotech Sector

Investors seeking opportunities in the biotechnology sector should keep a close eye on MBX Biosciences, Inc. (MBX). This clinical-stage biopharmaceutical company, headquartered in Carmel, Indiana, focuses on the discovery and..

RxSight, Inc. (RXST) Stock Analysis: Navigating the Challenges and Opportunities in Medical Devices

RxSight, Inc. (NASDAQ: RXST), a pioneering player in the medical devices sector, is capturing attention with its innovative Light Adjustable Lens (LAL) technology. Specializing in the post-cataract surgery market, RxSight’s..

Avanos Medical, Inc. (AVNS) Stock Analysis: Navigating Challenges with Strategic Healthcare Solutions

Avanos Medical, Inc. (NYSE: AVNS), a prominent player in the medical devices sector, is a company that individual investors might want to keep an eye on, especially given its unique..

Niagen Bioscience, Inc. (NAGE) Stock Analysis: Unveiling a 125% Potential Upside in Biotech

Investors looking to capitalize on the burgeoning sector of biotechnology should take a closer look at Niagen Bioscience, Inc. (NASDAQ: NAGE). With a market capitalization of $567.04 million, this healthcare-focused..

Tectonic Therapeutic, Inc. (TECX) Stock Analysis: Exploring a 353% Potential Upside

Tectonic Therapeutic, Inc. (NASDAQ: TECX) has emerged as a compelling opportunity for investors seeking exposure in the biotechnology sector. With its focus on innovative GPCR-targeted biologic medicines, Tectonic is strategically..

Emergent BioSolutions Inc. (EBS) Stock Analysis: Navigating a Niche in Public Health Preparedness

Emergent BioSolutions Inc. (NYSE: EBS) is carving out a distinct niche in the healthcare sector, focusing on preparedness and response solutions for public health threats. With a market capitalization of..

Intellia Therapeutics, Inc. (NTLA): Investor Outlook on a Potential 156.64% Upside in Gene Editing Innovations

Intellia Therapeutics, Inc. (NTLA), a trailblazer in the biotechnology sector, is capturing investor attention with its innovative approach to genome editing. Headquartered in Cambridge, Massachusetts, this clinical-stage company is at..

SI-BONE, Inc. (SIBN) Investor Outlook: With a 63.55% Potential Upside, What Lies Ahead?

SI-BONE, Inc. (NASDAQ: SIBN), a leader in the medical devices industry, is catching the eye of investors with a compelling potential upside of 63.55%. This healthcare sector player, headquartered in..

Celcuity Inc. (CELC) Stock Analysis: Unraveling a 4.48% Potential Upside in the Healthcare Biotech Sphere

Celcuity Inc. (CELC), a trailblazer in the biotechnology sector, is making waves with its innovative approach to targeted cancer therapies. Based in Minneapolis, Minnesota, this clinical-stage biotech company is dedicated..

ATAI Life Sciences N.V. (ATAI) Stock Analysis: Unveiling a 109.53% Potential Upside in Biotech Innovation

ATAI Life Sciences N.V. (NASDAQ: ATAI), a prominent player in the biotechnology sector, is making waves with its innovative approach to mental health treatment. Based in the Netherlands, this clinical-stage..

Sana Biotechnology, Inc. (SANA) Stock Analysis: A Promising 66% Upside in the Cell Therapy Market

Sana Biotechnology, Inc. (NASDAQ: SANA) is generating buzz among investors with its robust potential for growth in the biotechnology sector, particularly in the field of engineered cell therapies. With a..

SIGA Technologies Inc. (SIGA) Stock Analysis: Uncovering the Growth Potential Behind a 271.90% Revenue Surge

SIGA Technologies Inc. (NASDAQ: SIGA), a prominent player in the healthcare sector, specializes in the manufacturing of specialty and generic drugs. With a current market capitalization of $595.05 million, SIGA..

Surmodics, Inc. (SRDX) Stock Analysis: Navigating a Challenging Yet Promising Healthcare Landscape

Surmodics, Inc. (NASDAQ: SRDX), a key player in the healthcare sector specializing in medical devices, presents a complex yet intriguing scenario for investors. With its headquarters in Eden Prairie, Minnesota,..

Kamada Ltd. (KMDA) Stock Analysis: Exploring a Potential 105% Upside in the Healthcare Sector

Kamada Ltd. (NASDAQ: KMDA), a prominent player in the healthcare sector, is capturing investor attention with its robust pipeline of plasma-derived protein therapeutics and an impressive potential upside of over..

Auna SA (AUNA) Stock Analysis: Unpacking the 108.69% Potential Upside

Auna SA (AUNA), a Luxembourg-based healthcare giant, is garnering attention from investors with an enticing potential upside of 108.69%. Operating hospitals and clinics across Mexico, Peru, and Colombia, and offering..

Bicara Therapeutics Inc. (BCAX) Stock Analysis: Unveiling a Potential 95% Upside in the Biotech Sector

Bicara Therapeutics Inc. (NASDAQ: BCAX) is garnering significant attention from investors within the biotech sector, thanks to a remarkable potential upside of 95.28%. This clinical-stage biopharmaceutical company, headquartered in Boston,..

Embecta Corp. (EMBC) Stock Analysis: Is a 22% Upside Within Reach?

Embecta Corp. (NASDAQ: EMBC) is garnering attention in the healthcare sector, particularly from investors seeking opportunities in medical instruments and supplies. With a market cap of $798.91 million, this United..

Sonida Senior Living, Inc. (SNDA) Stock Analysis: Navigating Challenges with a 1.84% Potential Upside

Sonida Senior Living, Inc. (SNDA), a key player in the healthcare sector, specifically in the medical care facilities industry, has been a focal point for investors seeking opportunities in the..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds